Viewing Study NCT03901469

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-03-13 @ 11:21 AM
Study NCT ID: NCT03901469
Status: TERMINATED
Last Update Posted: 2025-10-07
First Post: 2019-03-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
Sponsor: Zenith Epigenetics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TNBC View
None ZEN003694 View
None ZEN-3694 View
None Talazoparib View
None Breast Cancer View
None PARPi View
None poly ADP ribose polymerase View
None bromodomain View
None BETi View